Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Innovation Council · Running

BIOACTION Bacteria Biofilm as bio-factory for tissue regeneration

Coordinator
Consiglio Nazionale Delle Ricerche, Italy
Runs
1 April 2023 to 30 September 2027
Status
Running
EU funding
€2.9m
Total cost
€2.9m
Partners
7 organisations in 5 countries
Type
European Innovation Council
Grant agreement
101098972

What the project is doing

In the project's own words, from its summary on CORDIS.

BIOACTION aims at developing a new methodology in implant technology based on functionalized bio-hydrogels that will convert the negative occurrence of biofilm-associated infections, the primary cause of implant infections and failure, into a positive resource. The main goal of BIOACTION is to transform implant-associated bacteria for the programmable production of specific proteins for in vivo cell recruitment and tissue regeneration, exploiting gene sequences loaded on engineered liposomes and phages, bound to hydrogel scaffolds.

BIOACTION will develop new biomimetic substrates that can transform biofilm into extracellular matrix for the regeneration of target tissues. It will establish a high versatile technology to be used as injectable materials and implant coatings for periodontal and peri-implant infection treatments. The proposed approach will be validated in two clinically relevant animal models: dental implant and permanent transcutaneous bone.

BIOACTION, would radically advance the future of infection treatment by revolutionizing the classical approaches leading to the improvement of state of care, health outcomes and to achieve huge socio-economic benefits. The project isstrongly interdisciplinary in nature involving expertise biomaterials, synthetic biology, phage and liposome technology, medicine. As a results, this innovative approach will bring the research and knowledge far beyond the current state-of-the-art and will lead, through the planned validation, as proof-of-concept of new materials and technique with a broader application in regenerative medicine.

Topics

Who is involved

OrganisationCityCountryRole
Consiglio Nazionale Delle RicercheRomaItalyCoordinator
Universite De LiegeLiegeBelgiumParticipant
Ao Forschungsinstitut DavosDavos PlatzSwitzerlandAssociatedpartner
Fundacio Institut De Bioenginyeria De CatalunyaBarcelonaSpainParticipant
In SRLUdineItalyParticipant
Universita Degli Studi Del Piemonte Orientale Amedeo AvogadroVercelliItalyParticipant
FerentisVilniusLithuaniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI